Achaogen (AKAO) Misses Q2 EPS by 16c

Achaogen (NASDAQ: AKAO) reported Q2 EPS of ($0.78), $0.16 worse than the analyst estimate of ($0.62). Revenue for the quarter came in at $1.27 million versus the consensus estimate of $2.4 million.

Cash, cash equivalents and short-term investments totaled $230.3 million, and restricted cash totaled $12.6 million at June 30, 2017.

For earnings history and earnings-related data on Achaogen (AKAO) click here.

You May Also Be Interested In

• Tesla plans 'flying' Roadster stunt at SpaceX Texas site as early as August
• Boost Run, Inc. (BRUN) Reports Q2 Revenue of $31.1M
• Reading (RDI) Tops Q2 EPS by 4c